Haemonetics Amends 2019 Long-Term Plan
Haemonetics has amended and restated its 2019 Long-Term Incentive Compensation Plan to adjust employee, director, and consultant compensation awards. This aligns the economic interests of participants with those of stockholders.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day